HETEROCYCLIC COMPOUNDS AS PROTEIN KINASES INHIBITORS

摘要

PURPOSE: A new heterocyclic compound and a pharmaceutical composition including thereof are provided to use the compound as an anti-cancer medicine by controlling an activation of a protein kinase of a growth factor receptor including c-Met. CONSTITUTION: A pharmaceutical composition including a new heterocyclic compound contains a protein tyrosine kinase activity inhibition compound to cure cancer, asthma, allergy, atopic dermatitis, inflammation disease, psoriasis or rheumatoid disease. The pharmaceutical composition additionally contains pharmaceutically acceptable salt, and a pharmaceutically acceptable carrier. The heterocyclic compound is marked as chemical formula 1. The pharmaceutical composition is injected to a patient who needs a treatment for the cancer.